Subvenite

Trials studying Subvenite

• phase3A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)recruitingn=450
• phase1A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participantscompletedn=133
• phase1Lamotrigine 25 mg Chewable Tablets, Non-Fastingcompletedn=32
• phase1Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditionscompletedn=32
• phase1Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditionscompletedn=32
• phase1Lamotrigine 25 mg Chewable Tablets, Fastingcompletedn=32
• phase1Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mgcompletedn=27
• phase1Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mgcompletedn=28